The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Europe Facial Fat Transfer Market would witness market growth of 10% CAGR during the forecast period (2019-2025).
Europe is expected to record a significant market share owing to the increased demand for facial fat transfer across the European countries. In Europe, most countries have a refund policy, which is a key driver of market growth. In addition, there is an increasing demand for minimally invasive cosmetic surgeries that enhance the youthfulness and demand for dermal fillers in this region.
Fat Transfer is not just a bioinert material, but a metabolic active substance and a live graft. Facial Fat Transfer procedures are therefore done only by experts or cosmetic surgeons. The procedure consists of collecting small amounts of fat from other parts of the body, such as the thighs, abdomen or hips, and injecting it into areas of the face that are depleted. It reduces lines and reshapes the face, improving the overall youthfulness of facial appearance.
During a surgical procedure, a small amount of fat obtained from other parts of the body, such as the abdomen, thighs, or hips, is typically inserted into various areas of the face with reduced volume. Body fat is highly compatible and well accepted by human skin and gives a natural look. The recent introduction of liposuction makes fat collection simpler. Advanced methods have made the process of removing fat from parts of the body and injecting it into particular parts of the body’s face or other parts secure. Technically, this process is referred to as autologous facial fat transfer.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
Scope of the Study
By Donor Site
By End Use
- Clinics & surgery centers
- Rest of Europe
- Allergan PLC
- Integra LifeSciences Holdings Corporation
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Ranfac Corporation
- Cytori Therapeutics, Inc.
- Suneva Medical, Inc.
- Dr. Korman Laboratories Ltd.
- Scivision Biotech, Inc.
- Teoxane Laboratories SA
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free